Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 1/20 | 0.44 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.43 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.41 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.41 |
| ▸ | MMP13 | P45452 | 1/20 | 0.40 |
| ▸ | REN | P00797 | 1/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8766144 | 1.00 | CTSS (0.44) | CTSSCTSKSLC7A5ITGB3ITGA2B | |
| SCHEMBL4778626 | 1.00 | CTSS (0.44) | CTSSCTSKSLC7A5ITGB3ITGA2B | |
| SCHEMBL25173080 | 0.89 | PPARG (0.40) | SLC7A5ITGB3ITGA2BMMP13REN | |
| SCHEMBL1401042 | 0.89 | MMP13 (0.46) | CTSSCTSKSLC7A5ITGB3ITGA2B | |
| SCHEMBL65502 | 0.89 | MMP13 (0.46) | CTSSCTSKSLC7A5ITGB3ITGA2B | |
| SCHEMBL2476924 | 0.89 | MMP13 (0.46) | CTSSCTSKSLC7A5ITGB3ITGA2B | |
| SCHEMBL1325201 | 0.88 | MMP13 (0.39) | SLC7A5ITGB3ITGA2BMMP13REN | |
| SCHEMBL5803685 | 0.88 | ADORA1 (0.48) | ITGB3ITGA2BMMP13ADORA1 | |
| SCHEMBL20585552 | 0.88 | TP53 (0.40) | ITGB3ITGA2BMMP13RENADORA1 | |
| SCHEMBL6557867 | 0.88 | ADORA1 (0.48) | ITGB3ITGA2BMMP13ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0624599-B1 | Derivatives of mono (6-amino-desoxy)cyclodextrin substituted in position 6 with an alpha aminoacid group, process of their preparation and applications | OREAL (FR) | 1997-07-30 | — | — | EP | claimed |
| US-12577262-B2 | Functionalized gold carbene napthaquinone complexes for use in the treatment of cancer | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2026-03-17 | — | — | US | disclosed |
| WO-2025136798-A1 | PROCESS FOR PREPARING (S)-1-((S)-2-AMINO-3-(4-METHOXYPHENYL)PROPANOYL)-N-(4-(HYDROXYMETHYL)PHENETHYL)-2-METHYLPYRROLIDINE-2-CARBOXAMIDE AND ITS INTERMEDIATES | MERCK SHARP & DOHME LLC (US) | 2025-06-26 | — | — | WO | disclosed |
| CN-120192280-A | Synthesis of amino acid derivatives containing 1,3, 4-oxadiazole thioether and application of amino acid derivatives in resisting plant bacterial diseases | 贵州大学 | 2025-06-24 | — | — | CN | disclosed |
| CN-119866342-A | Cyclic peptides for capturing interleukin-1 beta | 默沙东有限责任公司 | 2025-04-22 | — | — | CN | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| US-11834406-B2 | Conjugates of cell binding molecules with cytotoxic agents | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-12-05 | — | — | US | disclosed |
| CN-116953246-A | Method for detecting reaction intermediate by XFEL combined light activated unnatural amino acid | 中国科学院生物物理研究所 | 2023-10-27 | — | — | CN | disclosed |
| US-11767294-B2 | Conjugates of cell binding molecules with cytotoxic agents | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-09-26 | — | — | US | disclosed |
| US-5081246-A | Isoquinolino sulfonamino derivatives | Hidaka, Hiroyoshi (JP) | 1992-01-14 | — | — | US | disclosed |
| CN-1044098-A | Compounds with vascular smooth muscle relaxing activity | HIDAKA HIROYOSHI (JP) | 1990-07-25 | — | — | CN | disclosed |
| EP-0081838-B1 | CYCLOHEXYL AND PHENYL SUBSTITUTED ENKEPHALINS | G.D. Searle & Co. (US) | 1988-04-27 | — | — | EP | disclosed |
| US-4722922-A | RENIN INHIBITION | G. D. SEARLE & CO. (US) | 1988-02-02 | — | — | US | disclosed |
| EP-0122018-B1 | IMPROVEMENTS IN AND RELATING TO PHARMACOLOGICALLY ACTIVE TRIPEPTIDE DERIVATIVES | ELI LILLY AND COMPANY (US) | 1987-09-02 | — | — | EP | disclosed |
| US-4603121-A | ANALGESICS | G. D. SEARLE & CO. (US) | 1986-07-29 | — | — | US | disclosed |
| EP-0136720-A2 | Enkephalin analogs | G.D. Searle & Co. (US) | 1985-04-10 | — | — | EP | disclosed |
| US-4495178-A | Enkephalin analogs | G. D. SEARLE & CO. (US) | 1985-01-22 | — | — | US | disclosed |
| US-4407746-A | Cyclohexyl and phenyl substituted enkephalins | G. D. SEARLE & CO. (US) | 1983-10-04 | — | — | US | disclosed |
| EP-0081838-A1 | Cyclohexyl and phenyl substituted enkephalins | G.D. Searle & Co. (US) | 1983-06-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11767294-B2 | Conjugates of cell binding molecules with cytotoxic agents | CD4, CD2, CD47 | CTSS 1448/4885CTSK 1867/4885SLC7A5 1456/4885 |
| US-12577262-B2 | Functionalized gold carbene napthaquinone complexes for use in the treatment of cancer | RECQL, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HCCS | CTSS 4347/4885CTSK 2379/4885SLC7A5 626/4885 |
| US-11834406-B2 | Conjugates of cell binding molecules with cytotoxic agents | CD4, CD2, CD47 | CTSS 1483/4885CTSK 1890/4885SLC7A5 1465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.